Furthermore, the constitutively active STAT3 pathway in GBM-SCs contributes to the inhibition of T cell proliferation and activation, while this immunosuppressive status was diminished with STAT3 blockade (Wei et al., 2010). The gene discussed is STAT3; the disease is glioblastoma.